Table 1.
Latanoprostene bunod 0.024% (N = 24) | ||
---|---|---|
Study eye | Treated fellow eye | |
Total number of ocular TEAEs | 28 | 27 |
Subjects with ≥1 TEAE, n (%) | 21 (87.5) | 21 (87.5) |
Eye disordersa, n (% of subjects) | ||
Conjunctival hyperaemia | 12 (50.0) | 12 (50.0) |
Punctate keratitis | 13 (54.2) | 12 (50.0) |
Conjunctival disorder | 1 (4.2) | 1 (4.2) |
Eye pain | 1 (4.2) | 1 (4.2) |
Visual acuity reduced | 1 (4.2) | 1 (4.2) |
All subjects who received at least one dose of study drug
TEAE treatment-emergent adverse event
aSystem organ class preferred terms